Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors

Science

Volumn 303, Issue 5663, 2004, Pages 1512-1514

  Nie, Zhiguo ^a   Schweitzer, Paul ^a   Roberts, Amanda J ^a   Madamba, Samuel G ^a   Moore, Scott D ^b   Siggins, George Robert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; HORMONES; LIVING SYSTEMS STUDIES; NEUROLOGY;

ALCOHOL ABUSE; CELLULAR MECHANISMS;

ETHANOL;

ALCOHOL; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ALCOHOL; BEHAVIORAL RESPONSE; ETHANOL;

ALCOHOL ABUSE; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN NERVE CELL; CONTROLLED STUDY; GABAERGIC TRANSMISSION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STRESS; SYNAPTIC TRANSMISSION;

ALCOHOL DRINKING; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; EVOKED POTENTIALS; GAMMA-AMINOBUTYRIC ACID; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PATCH-CLAMP TECHNIQUES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GABA-A; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 1542377428     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1092550     Document Type: Article

References (30)

1. R. Krysiak, E. Obuchowicz, Z. S. Herman, Pol. J. Pharmacol. 52, 15 (2000).
2. J. M. Reul, F. Hotsboer, Curr. Opin. Pharmacol. 2, 23 (2002).
3. K. Van Pett et al., J. Comp. Neurol. 428, 191 (2000).
4. F. M. Dautzenberg, R. L. Hauger, Trends Pharmacol. Sci. 23, 71 (2002).
5. G. W. Smith et al., Neuron 20, 1093 (1998).
6. Z. Sarnyai, Y. Shaham, S. C. Heinrichs, Pharmacol. Rev. 53, 209 (2001).
7. I. Sillaber et al., Science 296, 931 (2002).
8. F. Holsboer, Curr. Opin. Investig. Drugs 4, 46 (2003).
9. L. A. Pohorecky, Alcohol. Clin. Exp. Res. 15, 438 (1991).
10. L. A. Pohorecky, Alcohol Alcohol. 25, 263 (1990).
11. G. R. Valdez et al., Alcohol. Clin. Exp. Res. 26, 1494 (2002).
12. X. Liu, F. Weiss, J. Neurosci. 22, 7856 (2002).
13. G. F. Koob et al., Alcohol. Clin. Exp. Res. 22, 3 (1998).
14. G. F. Koob, E. J. Nestler, J. Neuropsychiatry Clin. Neurosci. 9, 482 (1997).
15. G. F. Koob, Ann. N. Y. Acad. Sci. 909, 170 (2000).
16. H. E. Day, E. J. Curran, S. J. Watson Jr., H. Akil, J. Comp. Neurol. 413, 113 (1999).
17. P. Veinante, M. E. Stoeckel, M. J. Freund-Mercier, Neuroreport 8, 2985 (1997).
18. A. J. Roberts, H. Cole, G. R. Koob, Alcohol. Clin. Exp. Res. 20, 1289 (1996).
19. A. E. Ryabinin et al., Alcohol. Clin. Exp. Res. 26, 714 (2002).
20. M. Roberto, S. G. Madamba, S. D. Moore, M. K. Tallent, G. R. Siggins, Proc. Natl. Acad. Sci. U.S.A. 100, 2053 (2003).
21. See supporting data on Science Online.
22. Z. Nie, S. G. Madamba, G. R. Siggins, J. Pharmacol. Exp. Ther. 293, 654 (2000).
23. L. W. Hsin et al., Bioorg. Med. Chem. 10, 175 (2002).
24. H. Melis, R. Camarini, M. A. Ungless, A. Bonci, J. Neurosci. 22, 2074 (2002).
25. S. D. Moore, G. R. Siggins, unpublished data.
26. Y. A. Blednov et al., J. Pharmacol. Exp. Ther. 304, 30 (2003).
27. W. J. McBride, Pharmacol. Biochem. Behav. 71, 509 (2002).
28. G. S. Wand et al., Neuropsychopharmacology 26, 106 (2002).
29. K. S. LaForge, V. Yuferov, M. J. Kreek. Eur. J. Pharmacol. 410, 249 (2000).
30. B receptor antagonist CGP-55845A. Supported by National Institute on Alcohol Abuse and Alcoholism grants AA06420 and AA10994 and by National Institute on Drug Abuse grants DA03665 and DA136S8.